Strengthening Innovation Through Partnership
We’re proud to have signed a Memorandum of Understanding (MOU) with Twist Bioscience last month…
Continue Reading
-
-
We’re thrilled to announce our preferred partnership with Integrated DNA Technologies
NSG Bio is proud to join forces with IDT to empower our dynamic community of…
Continue Reading -
Accelerating Biotech Innovation Through Preferred Partnership
We’re proud to announce a preferred partnership between NSG Bio and GenScript, a global leader…
Continue Reading -
Continuing the Momentum: Year 2 of Preferred Partnership with Merck Life Science
We’re proud to share that NSG Bio is entering the second year of our preferred…
Continue Reading -
Thermo Fisher Scientific, NSG BIO Collaborate to Strengthen Singapore’s Biotech Startup Ecosystem
Thermo Fisher Scientific Inc, the world leader in serving science, has signed a strategic Memorandum…
Continue Reading -
Senti Bio Announces Positive Initial Clinical Data in Phase 1 Clinical Trial of SENTI-202
Senti Bio delivers exciting initial Phase 1 data for SENTI-202, with 2 of 3 Acute…
Continue Reading -
NSG BioLabs and Eppendorf Group partner to support biotech companies in Singapore
NSG BioLabs and Eppendorf Group partner to support biotech companies in Singapore
Continue Reading -
NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investments from Celadon Partners and ClavystBio
Fresh funding will be used to augment NSG BioLabs' infrastructure, services, and benefits for residents,…
Continue Reading -
SG BioLabs bags US$14.5 million funding; inks tie-ups with Merck, EnterpriseSG
The funds will go towards new facilities and co-working sites, likely around the Biopolis and…
Continue Reading -
VerImmune wants to help tackle cancer by teaching existing immunity to attack cancerous cells instead
VerImmune wants to offer new treatment possibilities for patients facing limited options or resistance to…
Continue Reading